Welsh stem cell firm wins fast-track filing path in Europe

LONDON (Reuters) – A biotech company founded by a Nobel prize winner has won the go-ahead from European regulators to begin the application process for conditional marketing authorization of a stem cell-based regenerative heart treatment.

—> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail